Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 791.91M P/E - EPS this Y 30.30% Ern Qtrly Grth -
Income -218.12M Forward P/E -3.75 EPS next Y -6.20% 50D Avg Chg -21.00%
Sales 288k PEG - EPS past 5Y - 200D Avg Chg -31.00%
Dividend N/A Price/Book 3.67 EPS next 5Y - 52W High Chg -53.00%
Recommedations 1.70 Quick Ratio 23.47 Shares Outstanding 63.82M 52W Low Chg 38.00%
Insider Own 0.01% ROA -29.24% Shares Float 47.76M Beta 1.17
Inst Own 112.01% ROE -46.75% Shares Shorted/Prior 9.31M/9.47M Price 18.36
Gross Margin - Profit Margin - Avg. Volume 796,129 Target Price 36.50
Oper. Margin -77,634.72% Earnings Date Aug 6 Volume 500,040 Change -1.55%
About Viridian Therapeutics, Inc.

Viridian Therapeutics, Inc., a biotechnology company, discover and develops treatments for serious and rare diseases. The company's product pipeline includes VRDN-001, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R humanized monoclonal antibodies targeting IGF-1R and incorporating half-life extension technology for the treatment of TED. It also provides VRDN-006 a preclinical program for autoimmune disease. In addition, the company offers VRDN-006 and VRDN-008 a preclinical program for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts.

Viridian Therapeutics, Inc. News
05/10/24 Viridian Therapeutics to Participate in Upcoming May Investor Conferences
05/09/24 Viridian Therapeutics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
05/09/24 Viridian Therapeutics Inc (VRDN) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
05/08/24 Viridian Therapeutics Inc (VRDN) Q1 2024 Earnings: Narrowing Losses Amidst Clinical Advancements
05/08/24 Viridian Therapeutics Highlights Recent Progress and Reports First Quarter 2024 Financial Results
05/03/24 Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/29/24 Viridian Therapeutics to Webcast First Quarter 2024 Financial Results on May 8, 2024
03/05/24 Viridian Therapeutics to Participate in the Leerink Partners Global Biopharma Conference
02/29/24 Viridian Therapeutics Full Year 2023 Earnings: Misses Expectations
02/27/24 Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
02/16/24 Viridian Therapeutics Appoints Jennifer Tousignant as Chief Legal Officer
10:00 PM Viridian Therapeutics Announces Pricing of Public Offering of Shares of Common Stock
04:01 PM Viridian Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock
01/08/24 Viridian Therapeutics to Present Key 2024 Corporate Priorities at J.P. Morgan Healthcare Conference
01/04/24 Viridian Therapeutics to Webcast Presentation at the 42nd Annual J.P. Morgan Healthcare Conference
12/18/23 Viridian Therapeutics Announces Positive Clinical Data in Healthy Volunteer Study and Selects VRDN-003 as Potential Best-in-Class Subcutaneous anti-IGF-1R Program with Extended Half-Life for Pivotal Development in Thyroid Eye Disease
11/21/23 Viridian Therapeutics to Participate in 6th Annual Evercore ISI HealthCONx Conference
11/13/23 Viridian Therapeutics Inc (VRDN) Reports Q3 2023 Financial Results and Corporate Progress
11/13/23 Viridian Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
11/08/23 Viridian Therapeutics to Participate in the Jefferies London Healthcare Conference
VRDN Chatroom

User Image NeverPop Posted - 1 week ago

$VRDN biggest fraud or new opportunity in the market

User Image briefingcom Posted - 1 week ago

$VRDN (-3%) downgraded to Neutral from Buy at B. Riley Securities; tgt lowered to $20 https://www.briefing.com/calendars/updown?Filter=Downgrades

User Image alejopa2001 Posted - 1 week ago

$VRDN https://www.tipranks.com/news/blurbs/viridian-therapeutics-a-strong-buy-on-successful-clinical-progress-and-market-potential-for-ted-therapy

User Image alejopa2001 Posted - 1 week ago

$VRDN https://www.tipranks.com/news/blurbs/analyst-issues-buy-rating-for-viridian-therapeutics-amid-positive-clinical-progress-and-strategic-bla-submission-plan

User Image erevnon Posted - 1 week ago

Needham reiterates Viridian Therapeutics $VRDN at Buy and maintains a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

User Image briefingcom Posted - 1 week ago

$VRDN: Viridian Therapeutics reports Q1 results, provides clinical update https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20240508070558VRDN&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

User Image epsguid Posted - 1 week ago

$VRDN reported a loss of $0.79, consensus was ($1.07) via @eWhispers #epsbeat http://eps.sh/d/vrdn

User Image Stock_Titan Posted - 1 week ago

$VRDN Viridian Therapeutics Highlights Recent Progress and Reports First Quarter 2024 Financial Results https://www.stocktitan.net/news/VRDN/viridian-therapeutics-highlights-recent-progress-and-reports-first-mptw1a89liap.html

User Image Blink182rulez Posted - 1 week ago

@xbibackto70s what do we think about $VRDN short before earnings tomorrow?

User Image Rodmon77 Posted - 2 weeks ago

$VRDN πŸ‘‰πŸƒβ€βž‘οΈπŸ’―

User Image Tshanky_ Posted - 2 weeks ago

$VRDN πŸ”₯

User Image MUNEMAKER Posted - 2 weeks ago

$VRDN Well Tepezza brought in half the VRDN market cap in the most recent qtr. So that's cool haha

User Image _www_larval_com_ Posted - 2 weeks ago

$MULN -5%[-21%] $VRDN -4%[4%] $TTOO -3%[-10%] most notable movement into the final minutes of trading.

User Image Rodmon77 Posted - 2 weeks ago

$VRDN Sleeper and Potential Runner πŸƒβ€βž‘οΈπŸƒβ€βž‘οΈπŸ§β€β™‚οΈ

User Image alejopa2001 Posted - 04/30/24

$VRDN back to $19 soon

User Image Montygo2020 Posted - 04/30/24

$VRDN

User Image Blink182rulez Posted - 04/29/24

$VRDN pathetic

User Image Stock_Titan Posted - 04/29/24

$VRDN Viridian Therapeutics to Webcast First Quarter 2024 Financial Results on May 8, 2024 https://www.stocktitan.net/news/VRDN/viridian-therapeutics-to-webcast-first-quarter-2024-financial-1mysepa9g4as.html

User Image MUNEMAKER Posted - 04/26/24

$VRDN Pathetic bounce

User Image aliliimr Posted - 04/25/24

$VRDN added at 12.4

User Image KWalzz Posted - 04/24/24

$VRDN mad move. is Scott Myers back?

User Image alejopa2001 Posted - 04/24/24

$VRDN WTF is this?

User Image MUNEMAKER Posted - 04/24/24

$VRDN Any apparent justification for this other than the dead time between catalysts and the typical sector pressure?

User Image frontiere Posted - 04/19/24

$SLRN Accelyrin ref=$4.96 long starter with partial stop-loss below 4.8 in case it’s not a bottom… +pending more due dil EOY cash 721 add in 30M refund from CRO =$751M βž”>$200m negative EV (though annual cash burn almost half of cash on hand). busted IPO, a long saga of weirdness, but IL-17a inhibitor and tons of cash. HS Phase 3 in 2H24 Comp $MLTX Moonlake positive EV=~$2.1B ⁉️ + comp $VRDN Viridian positive EV=~+300m after Jan financing β€” whose data they dunk on in their latest deck.

User Image NeverPop Posted - 04/19/24

$VRDN -38% YTD Not terrible

User Image Rodmon77 Posted - 04/19/24

$VRDN Manipulated badly to the downside for no apparent reason πŸ”₯

User Image R_NW Posted - 1 month ago

$VRDN Added a position earlier in the week.

User Image G101SPM Posted - 1 month ago

#OPTIONACTION $CFG May 35 calls (volume: 3280, open int: 10, implied vol: ~38%, prev day implied vol: 35%). Co is confirmed to report earnings April 17 before the open. $GILD Weekly May03 69 calls (volume: 14.9K, open int: 0, implied vol: ~28%, prev day implied vol: 26%). 14.9K traded in a single transaction. Co is confirmed to report earnings April 25 after the close. $VRDN May 15 puts are seeing interest with the underlying stock down 6% (volume: 5000, open int: 0, implied vol: ~86%, prev day implied vol: 74%). Nearly all the volume occurred in a single transaction. Co is expected to report earnings early May.K $SLG Jun 55 puts are seeing interest with the underlying stock down 7% (volume: 2510, open int: 0, implied vol: ~56%, prev day implied vol: 52%). Co is confirmed to report earnings April 17 after the close.

User Image Stock_Titan Posted - 1 month ago

$VRDN Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://www.stocktitan.net/news/VRDN/viridian-therapeutics-announces-inducement-grants-under-nasdaq-7pergfgvh6zj.html

User Image danieltanner Posted - 1 month ago

$VRDN is a 3 month low bad?

Analyst Ratings
HC Wainwright & Co. Buy May 9, 24
Oppenheimer Outperform May 9, 24
Ladenburg Thalmann Neutral May 9, 24
B. Riley Securities Neutral May 9, 24
Needham Buy May 9, 24
B. Riley Securities Buy Mar 21, 24
Needham Buy Mar 20, 24
HC Wainwright & Co. Buy Feb 29, 24
Wedbush Outperform Feb 28, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Fairmount Funds Management LLC Director Director Jan 22 Buy 21.00 476,190 9,999,990 1,839,954 01/24/24
Meisner Lara Chief Legal Officer Chief Legal Officer Jun 02 Sell 24.75 7,500 185,625 29,971 06/06/23
Meisner Lara Chief Legal Officer Chief Legal Officer Jun 02 Option 17.01 7,500 127,575 35,097 06/06/23
Myers Scott Dunseth Chief Executive Offi.. Chief Executive Officer Apr 12 Buy 25.3697 4,000 101,479 259,500 04/12/23
Meisner Lara General Counsel and.. General Counsel and Secretary Mar 09 Sell 29.07 29,971 871,257 03/10/23
Violin Jonathan Chief Executive Off.. Chief Executive Officer Feb 02 Sell 36.8 50,000 1,840,000 480,905 02/07/23
Violin Jonathan Chief Executive Off.. Chief Executive Officer Feb 02 Option 0.15 50,000 7,500 530,905 02/07/23
Meisner Lara General Counsel and.. General Counsel and Secretary Jan 23 Sell 35.66 6,843 244,021 01/25/23
Meisner Lara General Counsel and.. General Counsel and Secretary Jan 23 Option 18.52 6,843 126,732 6,843 01/25/23
Katz Barrett Chief Medical Office.. Chief Medical Officer Jan 13 Sell 37.11 29,000 1,076,190 01/18/23
Katz Barrett Chief Medical Office.. Chief Medical Officer Jan 13 Option 23.03 29,000 667,870 24,853 01/18/23
Katz Barrett Chief Medical Office.. Chief Medical Officer Jan 09 Sell 34.17 60,000 2,050,200 01/11/23
Katz Barrett Chief Medical Office.. Chief Medical Officer Jan 09 Option 23.03 60,000 1,381,800 47,377 01/11/23
Meisner Lara General Counsel and.. General Counsel and Secretary Dec 15 Option 23.03 1,597 36,779 1,297 12/19/22
Meisner Lara General Counsel and.. General Counsel and Secretary Dec 15 Sell 28.26 1,597 45,131 12/19/22
Meisner Lara General Counsel and.. General Counsel and Secretary Dec 12 Option 23.03 16,256 374,376 15,656 12/14/22
Meisner Lara General Counsel and.. General Counsel and Secretary Dec 12 Sell 28.09 16,256 456,631 12/14/22
Fairmount Funds Management LLC - - Aug 17 Buy 23.50 425,531 9,999,978 1,363,764 08/19/22
Violin Jonathan Chief Executive Off.. Chief Executive Officer Jun 01 Sell 12.20 30,000 366,000 480,905 06/02/22
Violin Jonathan Chief Executive Offi.. Chief Executive Officer May 02 Sell 13.04 30,000 391,200 510,905 05/04/22
Violin Jonathan Chief Executive Off.. Chief Executive Officer Apr 01 Sell 18.93 30,000 567,900 540,905 04/05/22
Violin Jonathan Chief Executive Off.. Chief Executive Officer Feb 01 Sell 19.06 30,000 571,800 600,905 02/03/22